No variable specified
St. Joseph’s Hospital joins oncology group
by Staff Reports
August 14, 2013 01:51 PM | 1413 views | 0 0 comments | 17 17 recommendations | email to a friend | print
In a news release, St. Joseph’s Hospital in Sandy Springs announced last week it has become the newest satellite member of the Radiation Therapy Oncology Group, an international research organization dedicated to the testing and application of the highest-quality cancer treatment.

This means that cancer patients treated at St. Joseph’s will be able to enroll in clinical trials that focus on discovering the best treatment options for a number of common types of cancer. It also means that residents in the northern part of Atlanta have easier access to the latest care provided at Emory University Hospital, the top-ranked hospital in the state by U.S. News & World Report.

“This approval comes as affirmation of our promise to the community that St. Joseph’s Hospital and Emory are committed to progress and improving outcomes against all cancers,” said Dr. Peter Rossi, medical director of radiation oncology at St. Joseph’s and assistant professor of radiation oncology at the Emory University School of Medicine and Winship Cancer Institute. “With credentialing now for enrollment on national studies, this is a statement of the quality of cancer care that we can offer, which is unrivaled north of Emory. We are excited to link our clinical trials program to the community in this way.”

Through the group affiliation, Rossi said, St. Joseph’s “will be able to offer high-quality clinical trials aiming to improve survival and quality of life, to evaluate new forms of radiotherapy delivery, including stereotactic radiotherapy and brachytherapy in the context of clinical research and to test new systemic therapies, including chemotherapeutic drugs, hormonal strategies, biologic agents, and new classes of cytostatic, cytotoxic, and targeted therapies” on the campus of St. Joseph Hospital.

The group, headed by the executive director of Winship, Dr. Walter J. Curran Jr., is conducting more than 45 clinical trials seeking to identify best therapies for patients with many malignancies, including brain tumors, head and neck or lung cancer, and prostate or breast cancer. Nearly every major cancer center in North America is a member of this research group.

The group approval for clinical trials means that patients at St. Joseph’s also will have access to trials conducted by the National Cancer Institute as well as to the multidisciplinary coordination of care for which Winship has been repeatedly recognized.

Information: www.stjosephsatlanta.org.
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
*We welcome your comments on the stories and issues of the day and seek to provide a forum for the community to voice opinions. All comments are subject to moderator approval before being made visible on the website but are not edited. The use of profanity, obscene and vulgar language, hate speech, and racial slurs is strictly prohibited. Advertisements, promotions, spam, and links to outside websites will also be rejected. Please read our terms of service for full guides